OrbusNeich Medical Group Holdings Limited (FRA:Q8T)

Market Cap	331.17M -12.7%
Revenue (ttm)	143.68M +11.5%
Net Income	34.63M +5.1%
EPS	0.04 +5.7%
Shares Out	n/a
PE Ratio	9.56
Forward PE	8.65
Dividend	0.03 (5.65%)
Ex-Dividend Date	Sep 18, 2025

Volume	n/a
Average Volume	44
Open	0.3500
Previous Close	0.3700
Day's Range	0.3500 - 0.3500
52-Week Range	0.3140 - 0.6550
Beta	n/a
RSI	44.98
Earnings Date	Mar 6, 2026

About FRA:Q8T

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expan...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2001
• Employees: 2,025
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: Q8T

Financial Performance

In 2024, FRA:Q8T's revenue was $164.10 million, an increase of 6.65% compared to the previous year's $153.87 million. Earnings were $39.72 million, a decrease of -11.88%.

Financial numbers in USD